Подписаться
Gabrielle Couchy
Gabrielle Couchy
Подтвержден адрес электронной почты в домене inserm.fr
Название
Процитировано
Процитировано
Год
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
K Schulze, S Imbeaud, E Letouzé, LB Alexandrov, J Calderaro, ...
Nature genetics 47 (5), 505-511, 2015
16302015
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
C Guichard, G Amaddeo, S Imbeaud, Y Ladeiro, L Pelletier, IB Maad, ...
Nature genetics 44 (6), 694-698, 2012
15292012
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
C Guichard, G Amaddeo, S Imbeaud, Y Ladeiro, L Pelletier, IB Maad, ...
Nature genetics 44 (6), 694-698, 2012
15292012
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
Y Ladeiro, G Couchy, C Balabaud, P Bioulac‐Sage, L Pelletier, ...
Hepatology 47 (6), 1955-1963, 2008
8542008
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry
P Bioulac‐Sage, S Rebouissou, C Thomas, JF Blanc, J Saric, A Sa Cunha, ...
Hepatology 46 (3), 740-748, 2007
6272007
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
J Calderaro, G Couchy, S Imbeaud, G Amaddeo, E Letouzé, JF Blanc, ...
Journal of hepatology 67 (4), 727-738, 2017
5852017
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
S Rebouissou, M Amessou, G Couchy, K Poussin, S Imbeaud, C Pilati, ...
Nature 457 (7226), 200-204, 2009
5272009
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
JC Nault, S Datta, S Imbeaud, A Franconi, M Mallet, G Couchy, E Letouzé, ...
Nature genetics 47 (10), 1187-1193, 2015
4922015
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience
P Bioulac‐Sage, H Laumonier, G Couchy, B Le Bail, A Sa Cunha, ...
Hepatology 50 (2), 481-489, 2009
4832009
Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation
JC Nault, G Couchy, C Balabaud, G Morcrette, S Caruso, JF Blanc, ...
Gastroenterology 152 (4), 880-894. e6, 2017
3562017
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection
JC Nault, A De Reyniès, A Villanueva, J Calderaro, S Rebouissou, ...
Gastroenterology 145 (1), 176-187, 2013
3442013
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
C Pilati, M Amessou, MP Bihl, C Balabaud, JT Van Nhieu, V Paradis, ...
Journal of Experimental Medicine 208 (7), 1359-1366, 2011
2712011
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
C Pilati, M Amessou, MP Bihl, C Balabaud, JT Van Nhieu, V Paradis, ...
Journal of Experimental Medicine 208 (7), 1359-1366, 2011
2712011
Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting
B Beuselinck, S Job, E Becht, A Karadimou, V Verkarre, G Couchy, ...
Clinical cancer research 21 (6), 1329-1339, 2015
2662015
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation
C Pilati, E Letouzé, JC Nault, S Imbeaud, A Boulai, J Calderaro, ...
Cancer cell 25 (4), 428-441, 2014
2652014
Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression
S Rebouissou, A Franconi, J Calderaro, E Letouzé, S Imbeaud, C Pilati, ...
Hepatology 64 (6), 2047-2061, 2016
2542016
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
E Letouzé, J Shinde, V Renault, G Couchy, JF Blanc, E Tubacher, ...
Nature communications 8 (1), 1315, 2017
2462017
Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response
S Caruso, AL Calatayud, J Pilet, T La Bella, S Rekik, S Imbeaud, ...
Gastroenterology 157 (3), 760-776, 2019
1542019
Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma
JC Nault, Y Martin, S Caruso, TZ Hirsch, Q Bayard, J Calderaro, C Charpy, ...
Hepatology 71 (1), 164-182, 2020
1522020
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
Q Bayard, L Meunier, C Peneau, V Renault, J Shinde, JC Nault, I Mami, ...
Nature Communications 9 (1), 5235, 2018
1422018
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20